The response to therapy shows great variation among cancer patients, even when patients are diagnosed with the same type of cancer. The main reason is that no two tumors are the same; tumors are composed of many different cell types and the specific composition and functioning of a tumor affects the response to treatment. By viewing tumors as complex systems, the use of mathematical models can help to better describe and understand the relationship between composition of the tumor and its behavior. Using clinical data and knowledge of cancer biology, we develop such models to study what determines a tumor's response to treatment. These insights may help to improve cancer drugs and increase the chances of the positive response to treatment.
In our group we take a multidisciplinary and holistic approach to provide a functional understanding of drugs response in the tumor microenvironment to improve precision oncology.
Ó. Lapuente-Santana$, J. Kant$, F. Eduati. npj Precision Oncology, 2024. ($ co-first authors)
Ó. Lapuente-Santana$, G. Sturm$, J. Kant, M. Ausserhofer, C. Zack, M. Zopoglou, N. McGranahan, D. Rieder, Z. Trajanoski, N. F. d C. C. de Miranda, F. Eduati#, F. Finotello#. iScience, 2024. ($ co-first authors, # co-last authors)
M. van Genderen$, J. Kneppers$, A. Zaalberg$, E. Bekers, A. M. Bergman#, W. Zwart#, F. Eduati#. npj Systems Biology and Applications, 2024. ($ co-first authors, # co-last authors)
M. Yelleswarapu, S. Spinthaki, T. F. A. de Greef, F. Eduati. JoVE. 2023.
M. van Santvoort, Ó. Lapuente-Santana, F. Finotello, P. van der Hoorn#, F. Eduati#. bioRxiv. 2023. (# co-last authors)
M. Passier, M. van Genderen, A. Zaalberg, J. Kneppers, E. Bekers, A. M. Bergman#, W. Zwart#, F. Eduati#. Cancer Research Communications. CRC-23-0097, 2023. (# co-last authors)
E. Visser$, S. A.A.M. Genet$, R. P.P.A. de Kock, B. E.E.M. van den Borne, M. Youssef-El Soud, H. N.A. Belderbos, G. Stege, M. E.A. de Saegher, S. C. van 't Westeinde, L. Brunsveld, M. A. C. Broeren, D. van de Kerkhof, B. A.L.M. Deiman, F. Eduati#, V. Scharnhorst#. Lung Cancer. 178, 28-36, 2023. ($ co-first authors, # co-last authors)
L. Kolmar$, A. Autour$, X. Ma, B. Vergier, F. Eduati#, C. A. Merten#. Trends in Cell Biology, 32(11), 847-961, 2022. ($ co-first authors, # co-last authors)
Ó. Lapuente-Santana, M. van Genderen, P. A. J. Hilbers, F. Finotello, F. Eduati. Patterns, 2(8), 100293. 2021.
Ó. Lapuente-Santana, F. Eduati. Frontiers in Oncology, 10:1027. 2020.
F. Eduati, P. Jaaks, J. Wappler, T. Cramer, C. A. Merten, M. J. Garnett, J. Saez-Rodriguez. Molecular Systems Biology, 16(2),e8664. 2020.
F. Eduati$, R. Utharala$, D. Madhavan, U.P. Neumann, T. Longerich, T. Cramer, J. Saez- Rodriguez#., C. Merten#. Nature Communications, 9(1):2434, 2018. ($ co-first authors, # co-last authors)
F. Finotello, F. Eduati. Frontiers in Oncology, 8, 1–9. 2018.
F. Eduati, V. Doldàn-Martelli, B. Klinger, T. Cokelaer, A. Sieber, F. Kogera, M. Dorel, M. J. Garnett, N. Blüthgen#, J. Saez-Rodriguez#. Cancer Research, 77(12):3364-3375, 2017. (# co-last authors)
F. Eduati$, L. M. Mangravite$, T. Wang*, H. Tang*, J. C. Bare, R. Huang, T. Norman, M. Kellen, M. P. Menden, J. Yang, X. Zhan, R. Zhong, G. Xiao, M. Xia, N. Abdo, O. Kosyk, The NIEHS-NCATS-UNC DREAM Collaboration, S. Friend, A. Dearry, A. Simeonov, R. R. Tice, I. Rusyn, F. A. Wright, G. Stolovitzky, Y. Xie, and J. Saez-Rodriguez. Nature Biotechnology, 733(9):933-940, 2015. ($ co-first authors)
Since 2018 Assistant professor, Eindhoven University of Technology, NL
2013-2017 Postdoc, European Molecular Biology Laboratory (EMBL), DE & UK
2013 PhD in Bioengineering, University of Padova, IT
2008 MSc in Bioengineering, University of Padova, IT
Research interests: Systems approaches to precision and personalised medicine in oncology. Personal page at TU/e.
Since 2018 Postdoc, Eindhoven University of Technology, NL
2019-2021 Postdoc, Rijksuniversiteit Groeningen, NL
2019 PhD in Physical Organic Chemistry, Radboud University, NL
2012 MSc in Biotechnology, ETH Zurich, CH
Research project: Developing a microfluidic platform for the combinatorial screening of cancer biopsies to elucidate tumor-mediated response to drugs.
Since 2020 PhD student, Catharina Hospital & Eindhoven University of Technology, NL
2020 MSc in Medical Engineering, Eindhoven University of Technology, NL
Research project: Analyzing the clinical applicability of tumor markers in the diagnosis and treatment response evaluation of lung cancer patients.
Since 2021 PhD student, Eindhoven University of Technology, NL
2020 MSc in Industrial and Applied Mathematics, Eindhoven University of Technology, NL
Research project: Designing and analyzing random graph models for reconstruction of cell-cell interaction networks to understand differences in and between tumors.
Since 2023 PhD student, Eindhoven University of Technology, NL
2022 MSc in Systems Biology, Maastricht University, NL
Research project: Mechanistic understanding of tumor response to drugs from perturbation trascriptomics data.
Since 2023 PhD student, Catharina Hospital & Eindhoven University of Technology, NL
2022 MSc in Medical Engineering, Eindhoven University of Technology, NL
Research project: Implementation of up-front ctDNA analysis into lung cancer care and development of liquid biopsy-based decision support models.
Research project: Studying the effect of anticancer drugs on PD-L1 expression.
Research project: Revealing the spatial context of the TME using pathology slides and transcriptomics
Research project: Integrating imaging and liquid biopsies for lung cancer diagnosis.
Year(s) | Name | Position |
---|---|---|
2018-2023 | Óscar Lapuente-Santana | Erasmus student (2018), PhD student (2019-2023) |
2022 | Sofia Spinthaki | Internship (Erasmus+) |
2021-2022 | Joan Kant | Master thesis |
2021-2022 | Max Joosten | Master thesis |
2021-2022 | Max de Rooij | Master thesis |
2020-2021 | Margot Passier | Master thesis |
2020-2021 | Roy van Mierlo | Internship |
2019-2020 | Maisa van Genderen | Master thesis |
2018 | Kees van Dorp | Internship |